Deeks, E. Safinamide: first global approval. Drugs 75, — Edmondson, D. Molecular and mechanistic properties of the membrane-bound mitochondrial monoamine oxidases. Biochemistry 48, — Fahn, S. Fowler, J. Neuropsychopharmacology 40, — Glenner, G. The histochemical demonstration of monoamine oxidase activity by tetrazolium salts. Gnerre, C. Gornall, A.
Determination of serum proteins by means of the biuret reaction. Hare, M. Tyramine oxidase: a new enzyme system in liver. Henkel, V. Treatment of depression with atypical features: a meta-analytic approach. Psychiatry Res. Jenner, P. Neurology 47, S—S Jo, G. Discovery of monoamine oxidase A inhibitors derived from in silico docking. Korean Chem. Johnston, J. Some observations upon a new inhibitor of monoamine oxidase in brain tissue.
Knoll, J. Some puzzling pharmacological effects of monoamine oxidase inhibitors. Kopin, I. Health Perspect. Kumar, B. Recent developments on the structure-activity relationship studies of MAO inhibitors and their role in different neurological disorders.
RSC Adv. Lakhan, S. Lineweaver, H. The determination of enzyme dissociation constants. Lowry, O. Protein measurement with the Folin phenol reagent. Maggiorani, D. Monoamine oxidases, oxidative stress, and altered mitochondrial dynamics in cardiac ageing.
Mallajosyula, J. Manuck, S. A regulatory polymorphism of the monoamine oxidase-A gene may be associated with variability in aggression, impulsivity and central nervous system serotonergic responsivity.
Marx, W. Detecting the historical roots of research fields by reference publication year spectroscopy RPYS. Meyer, J. Elevated monoamine oxidase a levels in the brain: an explanation for the monoamine imbalance of major depression. Psychiatry 63, — Riederer, P. Neurotoxicology 25, — Clinical applications of MAO-inhibitors. Sano, M. Saura, J. Increased monoamine oxidase B activity in plaque-associated astrocytes of Alzheimer brains revealed by quantitative enzyme radioautography.
Neuroscience 62, 15— Schneider, N. Substantial improvements in large-scale redocking and screening using the novel HYDE scoring function. Aided Mol. Setini, A. Molecular characterization of monoamine oxidase in zebrafish Danio rerio. B Biochem. Sheydina, A. Molecular mechanisms of cardiomyocyte aging. Shih, J. Monoamine oxidase: from genes to behavior. Slotkin, T. Mary Bernheim and the discovery of monoamine oxidase.
Brain Res. Son, S. Structure of human monoamine oxidase A at 2. Thor, A. Introducing CitedReferencesExplorer CRExplorer : A program for reference publication year spectroscopy with cited references standardization. Tong, J. Distribution of monoamine oxidase proteins in human brain: implications for brain imaging studies.
Blood Flow Metab. Tripathi, A. Privileged scaffolds as MAO inhibitors: retrospect and prospects. Tzvetkov, N. Future Med. Pyrrolo-pyridinyl benzamides: BBB permeable monoamine oxidase B inhibitors with neuroprotective effect on cortical neurons. Van Eck, N. Software survey: VOSviewer, a computer program for bibliometric mapping. Scientometrics 84, — Yamada, M. Clinical pharmacology of MAO inhibitors: safety and future. Yeung, A.
Bibliometric study on functional magnetic resonance imaging literature — concerning chemosensory perception. Use of MAOIs typically requires diet restrictions and avoiding certain other medications because MAOIs can cause dangerously high blood pressure when taken with certain foods or medications. In spite of side effects, these medications are still a good option for some people. In certain cases, they relieve depression when other treatments have failed. Antidepressants such as MAOIs ease depression by affecting chemical messengers neurotransmitters used to communicate between brain cells.
Like most antidepressants, MAOIs work by ultimately effecting changes in the brain chemistry that are operational in depression. An enzyme called monoamine oxidase is involved in removing the neurotransmitters norepinephrine, serotonin and dopamine from the brain.
MAOIs prevent this from happening, which makes more of these brain chemicals available to effect changes in both cells and circuits that have been impacted by depression.
MAOIs also affect other neurotransmitters in the brain and digestive system, causing side effects. MAOIs are sometimes used to treat conditions other than depression, such as Parkinson's disease. Selegiline is available as a skin transdermal patch. Using a patch may cause fewer side effects than MAOIs taken by mouth.
If you're using the lowest dose patch, you may not need diet restrictions, but ask your doctor. Because of side effects and safety concerns, MAOIs are most often tried when other antidepressants don't work. Consider these issues and discuss them with your doctor before taking an MAOI :. Most antidepressants are generally safe, but the FDA requires that all antidepressants carry black box warnings, the strictest warnings for prescriptions. In some cases, children, teenagers and young adults under 25 may have an increase in suicidal thoughts or behavior when taking antidepressants, especially in the first few weeks after starting or when the dose is changed.
MAOIs are generally not prescribed for children, but anyone taking an antidepressant should be watched closely for worsening depression or unusual behavior. If you or someone you know has suicidal thoughts when taking an antidepressant, immediately contact a doctor or get emergency help. Keep in mind that antidepressants are more likely to reduce suicide risk in the long run by improving mood.
Talk to your doctor before you stop taking an MAOI. Stopping treatment with MAOIs has been associated with anxiety, agitation and insomnia, as well as flu-like symptoms such as sweating, chills, nausea, headache and feeling generally unwell malaise.
If you stop an MAOI suddenly, you're more likely to experience a withdrawal-type reaction, sometimes called discontinuation syndrome. Rarely, uncommon withdrawal symptoms such as confusion, detachment from reality psychosis and convulsions can occur. You may need to wait two or more weeks between the use of MAOIs and other antidepressants to avoid serotonin syndrome. During those two weeks, you should continue food and beverage restrictions and avoid taking drugs that can cause serious interactions with MAOIs.
Each person reacts differently to a particular antidepressant and may be more likely to have certain side effects. Because of this, one antidepressant may work better for you than another. When choosing an antidepressant, your doctor takes into account your symptoms, any health problems you have, other medications you take and what has worked for you in the past. Inherited traits play a role in how antidepressants affect you. In some cases, where available, results of special blood tests may offer clues about how your body may respond to a particular antidepressant.
However, other variables can affect your response to medication. It may take several weeks or longer before an antidepressant is fully effective and for initial side effects to ease up. Your doctor may recommend some dose adjustments or different antidepressants, but with patience, you and your doctor can find a medication that works well for you. There is a problem with information submitted for this request. Sign up for free, and stay up-to-date on research advancements, health tips and current health topics, like COVID, plus expert advice on managing your health.
Error Email field is required. Error Include a valid email address. To provide you with the most relevant and helpful information and to understand which information is beneficial, we may combine your e-mail and website usage information with other information we have about you.
If we combine this information with your PHI, we will treat all of that information as PHI, and will only use or disclose that information as set forth in our notice of privacy practices. You may opt-out of e-mail communications at any time by clicking on the Unsubscribe link in the e-mail. Our Housecall e-newsletter will keep you up-to-date on the latest health information.
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission. Any use of this site constitutes your agreement to the Terms and Conditions and Privacy Policy linked below.
Mayo Clinic is a nonprofit organization and proceeds from Web advertising help support our mission. Mayo Clinic does not endorse any of the third party products and services advertised. A single copy of these materials may be reprinted for noncommercial personal use only. This content does not have an English version. This content does not have an Arabic version. See more conditions. Monoamine oxidase inhibitors MAOIs.
Products and services. By Mayo Clinic Staff. Thank you for Subscribing Our Housecall e-newsletter will keep you up-to-date on the latest health information. People who experience anhedonia have a decreased ability to feel pleasure.
Learn causes, risk factors, and treatments for anhedonia. A SAD lamp can help alleviate symptoms of seasonal affective disorder. Learn more about SAD lamps, how to use them, features to look for, and products…. Bipolar disorder is a mental health condition that causes extreme fluctuations in thinking, mood, and behavior, known as depression and mania or….
Experts say mushrooms contain a number of nutrients, including potassium and B vitamins, that can boost physical as well as mental health. Health Conditions Discover Plan Connect. Mental Health. Medically reviewed by Alan Carter, Pharm.
How do MAOIs work? Understanding monoamine oxidase. Tyramine and foods to avoid. Other precautions. Types of MAOIs. Side effects of MAOIs. MAOIs and suicide risk.
The takeaway. Read this next. Combination Medication Therapies for Depression. Medically reviewed by Femi Aremu, PharmD. Medically reviewed by Timothy J. Legg, Ph. Herbs and Supplements for Diabetes.
0コメント